 (Br_J Ophthalmol 1995; 79: 771-776) 
Retinoblastoma is the most common primary intraocular neoplasm in children. Its histogenesis has been disputed for more than a century. The view that retinoblastoma was a glioma of the retina was first proposed by Virchow in 1864. 1 Flexner subsequently described rosettes as the characteristic of a well differentiated form of the tumour, suggesting that retinoblastoma was a neurocytoma of the retina.2 However, Bailey and Cushing considered the undifferentiated retinoblastic cells to be the progenitor of the tumour.3 Previous electron microscopic study by Tso and associates demonstrated that retinoblastoma cells shared many features with normal retinal photoreceptors, indicative of their neuronal origin.4 5 The advent of immunohistochemistry makes it possible to detect neuronal and glial elements in situ. Immunohistochemical studies have proved that retinoblastoma may arise from neuronal or neuroectodermal cells,6-1 or from primitive stem cells devoid of any glial differentiation.12 13 Astrocytes in the tumour were interpreted as being either reactive, in response to tumour growth and proliferation,'4 15 or neoplastic, based on their distribution pattern and cytological features.15 '8 Nevertheless, no agreement has been reached as to the existence of neoplastic glial cells in retinoblastoma.
In this histogenetic study we examined retinoblastomas along with astrocytic gliomas and cerebellar medulloblastomas in order to compare glial differentiation in retinoblastoma and the two types of brain tumour. We also determined relations between clinicopathological features and the expression of neuronal markers in a large retinoblastoma series.
Materials and methods
Formalin fixed and paraffin embedded tissues of 100 enucleated retinoblastomas, 18 astrocytic gliomas, and 15 medulloblastomas were randomly selected. Immunohistochemical staining was carried out by the avidin-biotin peroxidase complex method (ABC)19 to detect the presence of neuron specific enolase (NSE), glial fibrillary acidic protein (GFAP), and S-100 protein (S-100).
Sections of 5 ,um were cut and mounted on clean gelatin coated slides. They were routinely deparaffinised in xylene and hydrated in an ethanol series. Each step was followed by washing with TRIS buffered saline (TBS, pH 7-6, 0 05 M). Sections, except those stained for NSE, were treated with 0O05% trypsin for 20 minutes, the resulting digestion unmasking the antigen before immunohistochemistry. They were then incubated with 1% normal horse serum for 20 minutes to quench endogenous peroxidase activity. Anti-NSE (A589, Dako, CA, USA) and anti-GFAP (z334, Dako), as primary antisera, were diluted 1:1000 with TBS, while anti-S-100 (K524, Dako) gave best results in a 1:5 dilution. Primary antibody incubation was carried out in a moist chamber at 4°C overnight. Sections were then reacted with secondary antiserum (biotinylated goat anti-rabbit IgG, 1:200, Vector Laboratories, CA, USA) for 30 minutes and subsequently treated with the avidinbiotinylated peroxidase complex (1:100, Vector Laboratories) for 60 minutes. Sites of peroxidase activity were visualised by incubation with 0.3°/o hydrogen peroxide and freshly prepared 3, 3 diaminobenzidine in TRIS buffer to generate the colour reaction. Slides were counterstained with haematoxylin and mounted after dehydration through graded ethanol and xylene.
Non-immune rabbit serum was introduced as a negative control to substitute anti-NSE, GFAP, or S-100 in equal dilution to the primary antisera. A portion of norrnal retina within some of the retinoblastomas was used as a positive internal control. Consecutive Xu, Liu, Ni sections of both normal eye bulb and normal brain served as further positive controls. In evaluating the staining results, we concentrated on the morphology of the cells and differentiating of neoplastic from non-neoplastic positivity. The x2 test was applied and a level of p<0 05 was accepted as of statistical significance.
Results Table 1 lists the results of immunohistochemical staining of three types of tumours. In retinoblastomas NSE positive cells were neoplastic only, while GFAP or S-100 positive ones included both neoplastic and non-neoplastic cells. We found only GFAP or S-100 positive tumour cells in astrocytic gliomas, whereas there were both NSE and GFAP or S-100 positive in the tumour cells of medulloblastomas. Table 2 gives the expression of neuronal and glial markers in neoplastic cells of retinoblastomas.
NEURON SPECIFIC ENOLASE
With polyclonal antiserum against NSE, outer and inner segments of photoreceptor cells in normal retina showed positive staining ( Fig 1A) . Typical rods and cones could be identified, and seemed to stain equally well. However, neurons in the outer nuclear layer stained more darkly than those in the inner nuclear layer. Most ganglion cell bodies in the nerve fibre layer were also NSE positive. Tumour overlying normal retina and partially retaining a normal nuclear layer can be recognised ( Fig 1B) . (Fig 4A) . The GFAP positive areas were distributed randomly throughout the undifferentiated areas of the tumour and were not associated with blood vessels. In some cases other GFAP positive cells were found surrounding blood vessels, with oval nuclei, a variable amount of cytoplasm, and long thin multiprocesses (Fig 5A) . They were embedded in the tumour mass and their cell processes extended through the tumour. The former GFAP positive cells were interpreted as neoplastic glial cells, while the latter were considered to be reactive astrocytes. In 77 of 100 retinoblastomas (77%), we found a great variety of GFAP positive glial cells ranging from perivascular to scattered reactive, or even to extensive gliosis formed by Muller's cells. Glial cells in recognisable areas of optic nerve or retina seemed to proliferate in the tumour, with some of these foci being noncontiguous to the retina. Immunostaining for GFAP was not found in rosettes.
In some astrocytic gliomas (16/18, (Fig 4D) , including two positive for GFAP as well. These cells had the same morphology as well differentiated tumour cells in astrocytic gliomas (Fig 4E) and medulloblastomas ( Fig 4F) . We also noted that cells expressing S-100 were reactive astrocytes in retinoblastomas (Fig 5B) . The neuronal and glial markers of NSE, GFAP, and S-i 00 have been studied critically with various cell types and tumours. NSE, also called gamma-gamma enolase, is normally found in neurons and neuroendocrine cells of the APUD (amine precursor uptake and decarboxylation) system.20 21 In this study, we found identical positive staining in normal retina and most of the differentiated retinoblastoma cells. Neurons and their cell processes in the outer and inner nuclear layer, ganglion cells in normal retina, as well as tumour cells forming areas of rosettes in retinoblastomas were NSE positive. Cells forming FlexnerWintersteiner rosettes were presumed to represent neuronal differentiation.4 5 Other NSE positive cells without apparent rosette formation showed various degrees of differentiation; some of them resembled photoreceptors in the outer nuclear layer, representing considerable differentiation in undifferentiated retinoblastomas. Furthermore, none of the glial cells surrounding blood vessels were immunostained. These findings are in close agreement with those of the previous studies,6-9 15 13 Expression of GFAP has been interpreted as evidence of astroglial histogenesis, differentiation, or both. In human retina, glial cells in the nerve fibre and ganglion cell layers were always stained for GFAP and S-100. In our study, both markers were also detectable in retinoblastoma.
Two crucial questions must be addressed: (1) What are the criteria to identify positive glial cell types? (2) Are the positive glial cells differentiated from a precursor cell in retinoblastoma, or do they originate from a residual glial tissue as a reactive glial proliferation? Based on the cytological features of scanty cytoplasm and short processes, the location of the glial cells within the tumour, and the distance from uninvolved retina, we consider that the positive glial cells separated from normal components of the retina and developed from tumour. Also, the neoplastic glial cells in retinoblastoma resembled well differentiated tumour cells of astrocytic gliomas and medulloblastomas, suggesting an astroglial, rather than a Muller's cell,24 differentiation. However, the majority of the GFAP positive glial cells displayed features of reactive glial cells that were associated with blood vessels. These cells seemed to derive from astrocytes and Muller's cells in optic nerve and/or normal retina and then proliferate within the tumour. Hence, glial elements in retinoblastomas may represent a glial differentiation along a glial direction and a secondary proliferation of the -retinal glial cells in response to tumour growth.
Cells containing GFAP and S-100 in retinoblastoma possessed the morphological attributes of neoplastic cells, but were seldom present in large numbers and lacked the range of stages from mature to anaplastic transition. To our knowledge, there are no well documented reports of an immunopathological study of differentiation of glial elements in retinoblastoma. In addition, the reason that astrocytes preferentially express S-100 in formalin fixed and paraffin embedded materials may be that GFAP is not easily detectable, but often needed for optimal detection in immunohistochemical studies. '3 15 The study of medulloblastomas with NSE and GFAP or S-100 has shown components of glia and neuron in the tumour, suggesting the possibility of simultaneous neuronal and glial differentiation. The significance of neoplastic neuronal and glial cells within retinoblastomas is analogous to medulloblastomas to some extent. 3 25 Clinically, rosette formation in retinoblastoma is an important indicator for a favourable prognosis. [26] [27] [28] [29] ;,W,X i* < 3 t i a * 8 ' t ¢ 9 c / j Figure 5 Reactive astrocytes stained with glialfibrillary acidic protein (GFAP) (arrows) and S-100 in retinoblastoma (A and B, respectively) are closely related to blood vessels. These cells are much alike reactive astrocytes stained with GFAP in astrocytic glioma (C), having an oval nucleus, a variable amount of cytoplasm, and long thin multiprocesses (haematoxylin and eosin, bar indicates 100 ,um).
